edp1066
mAbexperimental
Clinical trial activity
1 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 24, 2018 (NCT03542994)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- edp1066
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03542994 | Phase 1 | Apr 24, 2018 | Evelo Biosciences, Medicines Evaluation Unit Ltd, University of Surrey |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Evelo Biosciences | Academic/Hospital | 1 | 1 | 1 | 2018 |
| Medicines Evaluation Unit Ltd | For profit | 1 | 0 | 1 | 2018 |
| University of Surrey | Academic/Hospital | 1 | 0 | 1 | 2018 |
3 organizations
Page 1 / 1